agilon health (NYSE:AGL) Cut to Market Perform at William Blair

William Blair lowered shares of agilon health (NYSE:AGL) from an outperform rating to a market perform rating in a research report sent to investors on Friday morning, Marketbeat.com reports.

Several other equities research analysts have also recently commented on the company. Evercore ISI cut their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Benchmark reiterated a “buy” rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Royal Bank of Canada restated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Three analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $7.81.

agilon health Stock Performance

AGL opened at $1.84 on Friday. The firm has a market capitalization of $757.12 million, a PE ratio of -2.52 and a beta of 0.60. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health has a twelve month low of $1.80 and a twelve month high of $13.76. The firm’s 50-day moving average price is $3.26 and its 200 day moving average price is $4.97.

Insider Activity

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

A number of large investors have recently made changes to their positions in the company. J.Safra Asset Management Corp boosted its position in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares in the last quarter. CWM LLC grew its position in shares of agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC purchased a new position in shares of agilon health during the second quarter worth approximately $60,000. Bleakley Financial Group LLC acquired a new position in shares of agilon health in the 1st quarter valued at $65,000. Finally, Allspring Global Investments Holdings LLC raised its position in agilon health by 17,790.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after purchasing an additional 10,674 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.